Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Three-dimensional imaging of upper tract urothelial carcinoma improves diagnostic yield and accuracy
Keishiro Fukumoto, Shigeaki Kanatani, Georg Jaremko, Zoe West, Yue Li, Kimiharu Takamatsu, Ibrahim Al Rayyes, Shuji Mikami, Naoya Niwa, Tomas Andri Axelsson, Nobuyuki Tanaka, Mototsugu Oya, Ayako Miyakawa, Marianne Brehmer, Per Uhlén
Keishiro Fukumoto, Shigeaki Kanatani, Georg Jaremko, Zoe West, Yue Li, Kimiharu Takamatsu, Ibrahim Al Rayyes, Shuji Mikami, Naoya Niwa, Tomas Andri Axelsson, Nobuyuki Tanaka, Mototsugu Oya, Ayako Miyakawa, Marianne Brehmer, Per Uhlén
View: Text | PDF
Research Article Oncology

Three-dimensional imaging of upper tract urothelial carcinoma improves diagnostic yield and accuracy

  • Text
  • PDF
Abstract

Upper tract urothelial carcinoma (UTUC) is a rare form of urothelial cancer with a high incidence of recurrence and a low survival rate. Almost two-thirds of UTUCs are invasive at the time of diagnosis; therefore, improving diagnostic methods is key to increasing survival rates. Histopathological analysis of UTUC is essential for diagnosis and typically requires endoscopy biopsy, tissue sectioning, and labeling. However, endoscopy biopsies are minute, and it is challenging to cut into thin sections for conventional histopathology; this complicates diagnosis. Here, we used volumetric 3-dimensional (3D) imaging to explore the inner landscape of clinical UTUC biopsies, without sectioning, revealing that 3D analysis of phosphorylated ribosomal protein S6 (pS6) could predict tumor grade and prognosis with improved accuracy. By visualizing the tumor vasculature, we discovered that pS6+ cells were localized near blood vessels at significantly higher levels in high-grade tumors than in low-grade tumors. Furthermore, the clustering of pS6+ cells was associated with shorter relapse-free survival. Our results demonstrate that 3D volume imaging of the structural niches of pS6 cells deep inside the UTUC samples improved diagnostic yield, grading, and prognosis prediction.

Authors

Keishiro Fukumoto, Shigeaki Kanatani, Georg Jaremko, Zoe West, Yue Li, Kimiharu Takamatsu, Ibrahim Al Rayyes, Shuji Mikami, Naoya Niwa, Tomas Andri Axelsson, Nobuyuki Tanaka, Mototsugu Oya, Ayako Miyakawa, Marianne Brehmer, Per Uhlén

×

Figure 2

Whole-mount multiplex immunostaining of UTUC samples.

Options: View larger image (or click on image) Download as PowerPoint
Whole-mount multiplex immunostaining of UTUC samples.
(A) Schematic indi...
(A) Schematic indicating where on the ureter UTUC sample #21LG was taken and which 2D layer showing the immunostaining for histone (blue), AE1/AE3 (cyan), pS6 (red), CD34 (green), and merged. (B) Cross section images of UTUC sample #5HG immunostained and segmented for AE1/AE3 and tumor region, respectively. Nuclei stained with histone nanobody. Segmentation lines in cyan. (C) Volume rendering of UTUC sample #5HG immunostained for pS6. Bounding box, 1,034 × 1,124 × 540 μm. (D) Cell-by-cell analysis of the percentage of pS6+ cells of the whole sample versus the tumor region (n = 21, ****P < 0.001 by Wilcoxon signed rank test). (E) Violin plot of the percentage of pS6+ cells in low-grade (n = 8) and high-grade (n = 11) UTUC samples (P = 0.002). (F) Volume rendering and cell-by-cell analysis of pS6+ cells in #13LG (left) and #3HG (right) UTUC samples. Bounding boxes, 786 × 540 × 470 μm (#13LG) and 1443 × 1304 × 644 μm (#3HG). (G) Violin plots of pS6+ cells in low-grade (n = 8) and high-grade (n = 11) UTUC samples analyzed for 5 randomly selected cross sections (z1-z5): z1, P = 0.026; z2, P = 0.083; z3, P = 0.302; z4, P = 0.021; and z5, P = 0.021.(H) ROC analysis of the pS6+ cell ratio in five 2D data sets (red, blue, green, magenta, and cyan) and the 3D data set (black). Scale bars: 100 μm (yellow), 250 μm (white), and x, y, z indicators 500 μm (white). The pseudocolors indicate low (blue) and high (red) expression levels of pS6. For the violin and box plots, the violin illustrates the distribution, the box center line indicates the median, the upper and lower boundaries of the indicate the upper and lower quartiles, and the whiskers indicate the minimum and maximum values. *P < 0.05, ***P < 0.005, ****P < 0.001 by Mann-Whitney U tests unless stated otherwise.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts